Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$211K Buy
584
+6
+1% +$2.05K 0.1% 170
2026
Q1
$203K Buy
+578
New +$206K 0.11% 161
2025
Q1
Sell
-593
Closed -$154K 186
2024
Q4
$154K Buy
593
+282
+91% +$83.7K 0.09% 180
2024
Q3
$100K Buy
+311
New +$102K 0.05% 182

Other funds holding AMGN

Values First Advisors's AMGN Position: Q2 2026 in Review

Values First Advisors increased its Amgen (AMGN) stake by 1% in Q2 2026, buying an estimated $2.05K and bringing the position to 584 shares worth $211K. The position accounts for 0.1% of the portfolio, ranked #170.

Values First Advisors first reported a position in AMGN in Q3 2024 and has held it in 4 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Values First Advisors held 584 shares of Amgen worth $211K as of Q2 2026.
  • Values First Advisors bought 6 Amgen shares in Q2 2026, an estimated $2.05K.
  • Amgen made up 0.1% of Values First Advisors's portfolio in Q2 2026, its #170 holding.
  • Values First Advisors first reported a position in Amgen in Q3 2024 and has held it in 4 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Values First Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.